Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07251712
PHASE1

Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet

Sponsor: Galmed Pharmaceuticals Ltd

View on ClinicalTrials.gov

Summary

Evaluate the exposure of of Aramchol from 2 different single doses of Aramchol meglumine tablet and to compare the exposure of steady state from a selected dose of Aramchol meglumine tablet.

Official title: A Phase I Open-label Trial in Healthy Volunteers to Evaluate the Exposure of Aramchol From Two Different Single Doses of an Aramchol Meglumine Tablet

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2025-12-25

Completion Date

2026-05-15

Last Updated

2026-03-17

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Aramchol

Aramchol tablet at 2 different single doses

Locations (1)

Hammersmith Medicines Research (HMR)

London, United Kingdom